Valuation: Astal Laboratories Limited

Market Cap 304.58Cr 3.16Cr 2.81Cr 2.63Cr 2.39Cr 4.51Cr 4.57Cr 32Cr 12Cr 155.12Cr 12Cr 12Cr 498.22Cr P/E 2025
9.45x
P/E 2026 8.37x
Enterprise Value 353.77Cr 3.67Cr 3.26Cr 3.05Cr 2.78Cr 5.24Cr 5.31Cr 37Cr 14Cr 180.17Cr 14Cr 13Cr 578.69Cr EV / Sales 2025
1.36x
EV / Sales 2026 1.31x
Free-Float
41%
Yield 2025 *
-
Yield 2026 -
1 day-1.93%
1 week-0.66%
Current month-1.93%
1 month-10.72%
3 months-21.01%
6 months+0.06%
Current year-19.93%
1 week 68
Extreme 68
72
1 month 62.8
Extreme 62.8
80.35
Current year 60.45
Extreme 60.45
91.9
1 year 60.45
Extreme 60.45
103.2
3 years 32.05
Extreme 32.05
131.7
5 years 5.41
Extreme 5.41
131.7
10 years 5.41
Extreme 5.41
131.7
Manager TitleAgeSince
Director of Finance/CFO 51 15/07/2023
Director TitleAgeSince
Director/Board Member - 08/09/2022
Director/Board Member - 08/09/2022
Director/Board Member - 08/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
-1.93%-0.66%-16.23%+116.97% 3.16Cr
+0.34%-2.91%+40.15%+113.46% 1,02500Cr
-0.60%-5.23%+38.21%+65.67% 62TCr
-0.11%-1.77%+9.77%+75.15% 46TCr
+0.00%-3.61%+60.22%+39.85% 35TCr
-0.52%-3.83%+21.88%+39.69% 34TCr
-1.34%-2.85%+11.88%+24.64% 27TCr
-0.98%-5.39%-4.64%+8.46% 25TCr
-0.34%-2.21%+36.32%+52.24% 22TCr
-0.75%-3.18%+32.17%+97.21% 18TCr
Average -0.65%-1.77%+22.97%+63.33% 37.18TCr
Weighted average by Cap. -0.31%-2.11%+30.69%+69.18%

Financials

2025 2026
Net sales 64Cr 66.11L 58.72L 54.92L 50.04L 94.21L 95.51L 6.64Cr 2.57Cr 32Cr 2.48Cr 2.43Cr 104.13Cr 248.64Cr 2.58Cr 2.29Cr 2.15Cr 1.95Cr 3.68Cr 3.73Cr 26Cr 10Cr 126.63Cr 9.7Cr 9.49Cr 406.72Cr
Net income 8.93Cr 9L 8L 8L 7L 13.21L 13.39L 93.15L 36.06L 4.55Cr 34.8L 34.05L 15Cr 15Cr 15.28L 13.57L 12.69L 11.56L 21.77L 22.07L 1.54Cr 59.43L 7.49Cr 57.36L 56.12L 24Cr
Net Debt 12Cr 11.98L 10.64L 10L 9L 17.08L 17.31L 1.2Cr 46.62L 5.88Cr 44.99L 44.02L 19Cr 49Cr 51.09L 45.38L 42.44L 38.67L 72.8L 73.8L 5.13Cr 1.99Cr 25Cr 1.92Cr 1.88Cr 80Cr
Logo Astal Laboratories Limited
Astal Laboratories Limited is an India-based company, which is engaged in the manufacturing and sale of pharmaceutical intermediates and bulk drugs. The Company is engaged in manufacturing fine chemicals, specialty chemicals and pharmaceutical intermediates. The Company’s products include HF Acid (2-Chloro-1,3-Bis (Dimethylamino) Trimethinium Hexafluorophosphate); 4-Methyl Sulphonyl Phenyl Acetic acid, (1R,3R)-methyl 1-(benzo[d][1,3] dioxol-5-yl)- 2,3,4,9-tetrahydro-1 H-pyrido[3,4-b]indole-3- carboxylate hydrochloride; L-Valine methyl ester Hydrochloride (LVMH); L-Valine benzyl ester Hydrochloride; N-[(2-Cyanobiphenyl-4-methyl)- L-Valine methyl ester Hydrochloride; D-Tryptophan Methyl Ester Hydrochloride; Moc-L-valine (N-(Methoxycarbonyl)-L-valine); 2-Ethoxyethyl-4-methylbenzene sulfonate; 2 Piperidin-4-yl-1H-benzoimidazole; Alpha, alpha-Dimethyl Phenyl Acetic Acid (2-Methyl-2-phenylpropionic acid); 2-(4-bromophenyl)-2-methylpropionic acid; Methyl 2,2-dimethylphenylacetate, and others.
Employees
22
Date Price Change Volume
01/26/01 ₹69.54 -1.93% 2,708
30/26/30 ₹70.91 +1.81% 5,759
29/26/29 ₹69.65 -1.92% 7,819
28/26/28 ₹71.01 -0.85% 14,222
25/26/25 ₹71.62 +2.31% 4,531
  1. Stock Market
  2. Stocks
  3. MACINTR Stock